Healthcare provider profile · identity verified

Wentao Hong, MD

Internal Medicine · URBANA, IL · NPI 1619463189

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	484	182
Amlodipine Besylate	Amlodipine Besylate	443	162
Lisinopril	Lisinopril	345	131
Levothyroxine Sodium	Levothyroxine Sodium	249	94
Losartan Potassium	Losartan Potassium	239	91
Metformin Hcl	Metformin Hcl	209	83
Metoprolol Succinate	Metoprolol Succinate	169	69
Hydrochlorothiazide	Hydrochlorothiazide	143	58
Omeprazole	Omeprazole	141	60
Gabapentin	Gabapentin	133	62
Simvastatin	Simvastatin	129	51
Furosemide	Furosemide	124	54
Lovastatin	Lovastatin	117	41
Carvedilol	Carvedilol	113	40
Tamsulosin Hcl	Tamsulosin Hcl	105	46
Eliquis	Apixaban	103	32
Pravastatin Sodium	Pravastatin Sodium	102	34
Metoprolol Tartrate	Metoprolol Tartrate	98	42
Jardiance	Empagliflozin	91	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	31
Potassium Chloride	Potassium Chloride	83	31
Albuterol Sulfate Hfa	Albuterol Sulfate	79	38
Alendronate Sodium	Alendronate Sodium	78	30
Allopurinol	Allopurinol	75	33
Rosuvastatin Calcium	Rosuvastatin Calcium	73	35
Spironolactone	Spironolactone	70	26
Pantoprazole Sodium	Pantoprazole Sodium	67	34
Clopidogrel	Clopidogrel Bisulfate	65	25
Sertraline Hcl	Sertraline Hcl	62	27
Finasteride	Finasteride	57	25
Glipizide Er	Glipizide	54	15
Montelukast Sodium	Montelukast Sodium	51	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	15
Atenolol	Atenolol	48	18
Warfarin Sodium	Warfarin Sodium	48	11
Fluticasone Propionate	Fluticasone Propionate	47	15
Glimepiride	Glimepiride	43	14
Meloxicam	Meloxicam	41	15
Olmesartan Medoxomil	Olmesartan Medoxomil	41	16
Escitalopram Oxalate	Escitalopram Oxalate	40	15
Chlorthalidone	Chlorthalidone	33	13
Naproxen	Naproxen	33	14
Xarelto	Rivaroxaban	33	11
Citalopram Hbr	Citalopram Hydrobromide	32	12
Ibuprofen	Ibuprofen	30	17
Ozempic	Semaglutide	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	14
Clonidine Hcl	Clonidine Hcl	28	12
Ezetimibe	Ezetimibe	28	suppressed
Glipizide	Glipizide	28	11
Trazodone Hcl	Trazodone Hcl	27	13
Klor-Con M20	Potassium Chloride	24	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Famotidine	Famotidine	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Fenofibrate	Fenofibrate	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Buspirone Hcl	Buspirone Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Topiramate	Topiramate	12	suppressed
Azithromycin	Azithromycin	11	11
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error